Announced
Completed
Synopsis
Vitrolife, a medical technology group, completed the acquisition of Igenomix, a provider of genetic testing services, from EQT Partners, a global investment organization, for $1.48bn. "The combination of Igenomix and Vitrolife brings together two successful organizations that have been committed to innovation and customer service, which will create a global leader in reproductive health focusing on providing the best possible products and services for the IVF clinics to succeed in their strive to support patients becoming parents,” Thomas Axelsson, Vitrolife CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.